Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-112972
Filing Date
2022-04-21
Accepted
2022-04-21 16:02:00
Documents
4
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A d298127ddef14a.htm DEF 14A 303608
2 GRAPHIC g298127g30h04.jpg GRAPHIC 23027
3 GRAPHIC g298127page030.jpg GRAPHIC 127139
4 GRAPHIC g298127page031.jpg GRAPHIC 125187
  Complete submission text file 0001193125-22-112972.txt   681773
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 22841395
SIC: 2835 In Vitro & In Vivo Diagnostic Substances